Goossens, Quentin http://orcid.org/0000-0002-3853-5495
Locsin, Miguel
Gharehbaghi, Sevda
Brito, Priya
Moise, Emily
Ponder, Lori A
Inan, Omer T
Prahalad, Sampath
Funding for this research was provided by:
Patricia Bowman Terwilliger Foundation (Patricia Bowman Terwilliger Foundation)
National Science Foundation Faculty Early Career Development Program (1749677)
Marcus Foundation funds (Marcus Foundation funds)
Children’s Healthcare of Atlanta (Children’s Healthcare of Atlanta)
Rheumatology Research Foundation (Rheumatology Research Foundation, Rheumatology Research Foundation)
Belgian American Educational Foundation (Belgian American Educational Foundation)
Article History
Received: 19 April 2023
Accepted: 3 June 2023
First Online: 20 June 2023
Declarations
:
: The study complied with the Declaration of Helsinki, was approved by ethics committees of Emory University and Georgia Institute of Technology, and written informed consent was obtained from the legally authorized representatives of the juvenile subjects, or the subjects themselves.
: Obtained.
: Dr. Prahalad has previously served on a macrophage activation syndrome adjudication committee for Novartis, and Dr. Inan is co-founder of Arthroba, Inc., but these relationships had no bearing on the work described in this manuscript. None of the other authors have any competing interests in the manuscript.